News & Events
Crinetics Announces April 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces April 2023 inducement grants: the stock options were granted as inducements material to 15 employees entering into...
READ MORECrinetics Announces March 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces March 2023 inducement grants: the stock options were granted as inducements material to eight employees entering into...
READ MORECrinetics Reports Fourth Quarter and Full Year 2022 Financial Results
Crinetics Pharmaceuticals reported financial results for the fourth quarter and year ended December 31, 2022
READ MORECrinetics Announces February 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces February 2023 inducement grants: the stock options were granted as inducements material to six employees entering into...
READ MORECrinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
Crinetics Pharmaceuticals will participate in a fireside chat at the annual SVB Securities Global Biopharma Conference on February 14, 2023.
READ MORECrinetics Announces January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces January 2023 inducement grants: the stock options were granted as inducements material to six employees entering into...
READ MORECrinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference
Crinetics provides a company update at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th at 3:00 p.m....
READ MORECrinetics Announces December 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals announces December 2022 inducement grants: the stock options were granted as inducements material to 12 employees entering into...
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
